Atlas Trials

Exemestane-RAD001-Metformin

Clinical trial NCT01627067 · TERMINATED

Trial details

NCT number
NCT01627067
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2012-09-01
Primary completion
2019-02-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.